- Home
- UCTT vs PHAR Comparison
UCTT vs PHAR Comparison
Compare UCTT & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCTT
- PHAR
- Stock Information
- Founded
- UCTT 1991
- PHAR 1988
- Country
- UCTT United States
- PHAR Netherlands
- Employees
- UCTT N/A
- PHAR N/A
- Industry
- UCTT Semiconductors
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- UCTT Technology
- PHAR Health Care
- Exchange
- UCTT Nasdaq
- PHAR Nasdaq
- Market Cap
- UCTT 1.0B
- PHAR 1.0B
- IPO Year
- UCTT 2004
- PHAR N/A
- Fundamental
- Price
- UCTT $24.38
- PHAR $15.26
- Analyst Decision
- UCTT Strong Buy
- PHAR Strong Buy
- Analyst Count
- UCTT 3
- PHAR 3
- Target Price
- UCTT $39.00
- PHAR $30.00
- AVG Volume (30 Days)
- UCTT 338.6K
- PHAR 12.0K
- Earning Date
- UCTT 10-27-2025
- PHAR 10-23-2025
- Dividend Yield
- UCTT N/A
- PHAR N/A
- EPS Growth
- UCTT N/A
- PHAR N/A
- EPS
- UCTT N/A
- PHAR N/A
- Revenue
- UCTT $2,141,100,000.00
- PHAR $339,836,000.00
- Revenue This Year
- UCTT N/A
- PHAR $16.63
- Revenue Next Year
- UCTT $4.45
- PHAR $6.77
- P/E Ratio
- UCTT N/A
- PHAR N/A
- Revenue Growth
- UCTT 14.28
- PHAR 22.44
- 52 Week Low
- UCTT $16.66
- PHAR $6.73
- 52 Week High
- UCTT $41.90
- PHAR $17.08
- Technical
- Relative Strength Index (RSI)
- UCTT 55.64
- PHAR 67.22
- Support Level
- UCTT $22.74
- PHAR $13.60
- Resistance Level
- UCTT $24.92
- PHAR $15.40
- Average True Range (ATR)
- UCTT 0.82
- PHAR 0.75
- MACD
- UCTT 0.09
- PHAR 0.14
- Stochastic Oscillator
- UCTT 82.00
- PHAR 90.61
About UCTT Ultra Clean Holdings Inc.
Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments Products and Services. Its principal markets are Americas, Asia Pacific and EMEA.
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.